Skip to content

Assessment of the Sub-gonal Arterial Revascularization of the Lower Limbs in Critical Ischemia by Venous Allograft Stored at + 4 ° C (ERAV)

Assessment of the Sub-gonal Arterial Revascularization of the Lower Limbs in Critical Ischemia by Venous Allograft Stored at + 4 ° C.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05101512
Acronym
ERAV
Enrollment
150
Registered
2021-11-01
Start date
2020-07-15
Completion date
2024-01-15
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occlusive Peripheral Arterial Disease, Venous Allogeneic Transplant

Brief summary

The main objective of this study is to assess the 2-year survival with salvage of the lower limb of patients who have undergone subgonal bypass grafting by venous allograft in the treatment of Occlusive Peripheral Arterial Disease (OPAD) in critical ischemia, in the absence of usable great saphenous vein.

Interventions

BEHAVIORALQuestionnaires on quality of life after surgery

Patient has to answer different questionnaire about quality of life, pain, functional scores

Sponsors

European Clinical Trial Experts Network
CollaboratorOTHER
Private Hospital Dijon
CollaboratorUNKNOWN
Ramsay Générale de Santé
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Man or woman over 18 (under effective contraception, hormonal contraceptive or intrauterine device, if premenopausal). * Patient with critical ischemia of the lower limb (stage 4-5-6 according to the Rutherford classification) requiring revascularization by sub-gonal bypass * Patient eligible and scheduled for bypass in venous allograft stored at + 4 ° C with distal anastomosis below the knee * Patient without usable autologous great Saphenous vein * Subject affiliated or beneficiary of a social security scheme * Patient having received the appropriate information concerning the objectives and procedures of the study and having declared his non-objection.

Exclusion criteria

* Use of unscheduled allografts * Patient requiring composite bypass in AGV + autologous venous material or prosthesis * Patient requiring replacement of infected prostheses * Patient with acute ischemia * Patient with severe coagulation disorders * Patient classified physical status score 4 * Patient participating in another clinical trial * Potential allergy to the graft * Protected patients: Adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision * Pregnant or breastfeeding woman

Design outcomes

Primary

MeasureTime frameDescription
Survival rate of patients at 2 years with lower limb rescue2 yearssurvival rate of patients at 2 years with lower limb rescue (time until death or amputation - amputation free survival)

Countries

France

Contacts

Primary ContactJean-François Oudet
jf.oudet@ecten.eu0683346567
Backup ContactMarie-Hélène Barba
mh.barba@ecten.eu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026